| 000 | 01844 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517000508.0 | ||
| 264 | 0 | _c20150731 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1521-0669 | ||
| 024 | 7 |
_a10.3109/08880018.2014.961214 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSawada, Akihisa | |
| 245 | 0 | 0 |
_aFeasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies. _h[electronic resource] |
| 260 |
_bPediatric hematology and oncology _cNov 2014 |
||
| 300 |
_a754-64 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xepidemiology |
| 650 | 0 | 4 | _aHaploidy |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xblood |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 650 | 0 | 4 |
_aNeuroblastoma _xblood |
| 650 | 0 | 4 | _aPeripheral Blood Stem Cell Transplantation |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aShimizu, Mariko | |
| 700 | 1 | _aIsaka, Kanako | |
| 700 | 1 | _aHiguchi, Kouhei | |
| 700 | 1 | _aMayumi, Azusa | |
| 700 | 1 | _aYoshimoto, Yuri | |
| 700 | 1 | _aKikuchi, Hiroaki | |
| 700 | 1 | _aKondo, Osamu | |
| 700 | 1 | _aKoyama-Sato, Maho | |
| 700 | 1 | _aYasui, Masahiro | |
| 700 | 1 | _aKawa, Keisei | |
| 700 | 1 | _aInoue, Masami | |
| 773 | 0 |
_tPediatric hematology and oncology _gvol. 31 _gno. 8 _gp. 754-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/08880018.2014.961214 _zAvailable from publisher's website |
| 999 |
_c24288378 _d24288378 |
||